Unknown

Dataset Information

0

Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival.

ABSTRACT: Mesenchymal stromal cells (MSCs) have been successfully used for the treatment of steroid-resistant graft-versus-host-disease (GvHD). However, the lack of early predictors of clinical responses impacts on the time at which to add further treatment and consequently the design of informative clinical trials. Here, we present the UK experience of one of the largest cohorts of GvHD patients undergoing MSC infusions so far reported. We show that clinical responses assessed as early as 1 week after MSC infusion predict patients' overall survival. In our cohort, cell dose, patients' age and type of organ involvement are crucial factors associated with clinical responses.

SUBMITTER: Galleu A 

PROVIDER: S-EPMC6916615 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Mesenchymal stromal cells (MSCs) have been successfully used for the treatment of steroid-resistant graft-versus-host-disease (GvHD). However, the lack of early predictors of clinical responses impacts on the time at which to add further treatment and consequently the design of informative clinical trials. Here, we present the UK experience of one of the largest cohorts of GvHD patients undergoing MSC infusions so far reported. We show that clinical responses assessed as early as 1 week after MS  ...[more]

Similar Datasets

Unknown Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease.
| S-EPMC6558336 | biostudies-literature
Unknown Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease.
| S-EPMC6251308 | biostudies-literature
Unknown Treatment with Mesenchymal Stromal Cells Overexpressing Fas-Ligand Ameliorates Acute Graft-versus-Host Disease in Mice.
| S-EPMC8745472 | biostudies-literature
Unknown Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers.
| S-EPMC7330053 | biostudies-literature
Unknown Adult human mesenchymal stromal cells and the treatment of graft versus host disease.
| S-EPMC3945047 | biostudies-other
Unknown Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease.
| S-EPMC6881464 | biostudies-literature
Unknown CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation.
| S-EPMC7986048 | biostudies-literature
Unknown Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.
| S-EPMC3026853 | biostudies-literature
Unknown An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.
| S-EPMC5291735 | biostudies-literature
Unknown Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease-a gut feeling.
| S-EPMC6864966 | biostudies-literature